CLINICAL_TRIALS
trial_result
· 2011-02-02
Clinical Trial Update: Safety of High-dose Tirofiban During Coronary Angioplasty [Phase 4]
Summary
Phase 4 trial updating the safety profile of high-dose tirofiban used during coronary angioplasty in patients with coronary artery disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: S. Anna Hospital | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED